Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1995-11-7
pubmed:abstractText
We evaluated the in vitro antibody production from peripheral blood mononuclear cells (PBMC) against HIV-1 proteins in infected adults. Fifty-four HIV-1 infected patients (four recent seroconverters, 15 asymptomatics with a CD4 count higher than 500/microliters, 27 asymptomatics with a CD4 count between 200 and 500/microliters and eight symptomatic patients) were tested. PBMC were incubated in the presence or absence of 1% pokeweed mitogen (PWM) at 37 degrees C for 8 days. Western blot assay, p24 antigen ELISA and anti-p24 antibody ELISA were performed on serum and culture supernatants. Spontaneous production of anti-env antibody in culture supernatants was evidenced in all subjects. All the positive supernatants for anti-core antibodies (18/54) were derived from asymptomatic patients. PBMC from recent seroconverters and from symptomatic patients did not produce any anti-core antibody. Antibody production decreased after stimulation with PWM. The concentration of p24 antigen did not significantly increase in p24 positive supernatants following acidification (P = 0.1), suggesting that the inability to detect p24 antibody was not due to the anti-p24 antibody complexed to p24 antigen in culture supernatants. In vitro production of anti-p24 antibodies was significantly more frequent in asymptomatic subjects with high CD4+ cell counts (P = 0.02) and was absent in recent seroconverters. This last finding suggests that during the initial phases of the infection, anti-p24 antibody production may be restricted to cells residing in lymphoid organs. In addition, the lower percentage of anti-core antibody in people with low CD4+ cell counts is not merely a consequence of the binding of the antibody to an increased amount of antigen, but probably reflects an impaired production or a sequestration of producing cells in lymphoid tissue during the late stages of the infection.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1358985, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1371925, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1500743, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1503683, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1671648, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1723280, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1737846, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1899349, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1899628, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1909874, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-1974765, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-2078296, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-2113075, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-2147550, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-2261128, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-2567244, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-2703528, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-2820544, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-2974045, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-2991618, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3016028, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3016902, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3024007, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3099912, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3126959, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3257430, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3299092, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3479517, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3492262, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3499462, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-3955884, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-6224088, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-7114072, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-7851008, http://linkedlifedata.com/resource/pubmed/commentcorrection/7554395-8095146
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0009-9104
pubmed:author
pubmed:issnType
Print
pubmed:volume
102
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
26-30
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
In vitro anti-HIV-1 antibody production in subjects in different stages of HIV-1 infection.
pubmed:affiliation
Clinica delle Malattie Infettive, Università di Milano, Italy.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't